Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00206453 | Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer | terminated | Phase 2 | 25 | Baylor Breast Care CenterOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00039455 | Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00523809 | Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor | terminated | Phase 2 | 5 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 28, 2013 | clinicaltrials |
| NCT00002772 | S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | terminated | Phase 3 | 602 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00005983 | S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer | terminated | Phase 3 | 98 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00025493 | S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer | terminated | Phase 2 | 27 | SWOG Cancer Research NetworkNETWORK | 0 | Jan 24, 2013 | clinicaltrials |
| NCT00674414 | Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery | terminated | Phase 2 | 82 | UNICANCEROTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00016276 | Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer | terminated | Phase 3 | 396 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00095888 | 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer | terminated | Phase 2 | 68 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00584753 | Molecular Imaging of Breast Cancer With Breast PET/CT | terminated | Phase 1 | 4 | University of California, DavisOTHER | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00960154 | PEAK PlasmaBlade™ 4.0 Versus Traditional Electrosurgery in Lumpectomy(PRECISE) | terminated | N/A | 50 | Medtronic Surgical TechnologiesINDUSTRY | 1 | Jan 8, 2013 | clinicaltrials |
| NCT01301911 | Study of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast Cancer | terminated | Phase 1 | 26 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00288444 | Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer | terminated | Phase 1 | 38 | Emory UniversityOTHER | 1 | Dec 18, 2012 | clinicaltrials |
| NCT00006032 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | terminated | Phase 2 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 11, 2012 | clinicaltrials |
| NCT00227656 | Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer | terminated | Phase 2 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 11, 2012 | clinicaltrials |
| NCT00817362 | Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer | terminated | Phase 2 | 29 | Infinity Pharmaceuticals, Inc.INDUSTRY | 2 | Dec 11, 2012 | clinicaltrials |
| NCT01277926 | Patterns of Care in Hormone-receptor Positive, Advanced Breast Cancer | terminated | — | 7 | AstraZenecaINDUSTRY | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00506064 | Melatonin Postoperative Sleep Study in Breast Cancer Patients | terminated | Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 5, 2012 | clinicaltrials |
| NCT00793546 | Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer | terminated | Phase 2 | 42 | PfizerINDUSTRY | 11 | Nov 5, 2012 | clinicaltrials |
| NCT01006785 | Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer | terminated | Phase 2 | 15 | Dexa Medica GroupINDUSTRY | 1 | Oct 18, 2012 | clinicaltrials |
| NCT01007890 | Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer(PT-304) | terminated | — | 134 | Precision TherapeuticsINDUSTRY | 1 | Oct 5, 2012 | clinicaltrials |
| NCT00036686 | Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy | terminated | N/A | 1 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT01473680 | Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients | terminated | — | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 13, 2012 | clinicaltrials |
| NCT00817531 | Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients | terminated | Phase 2 | 22 | Baylor Breast Care CenterOTHER | 1 | Aug 31, 2012 | clinicaltrials |
| NCT00555841 | Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue | terminated | Phase 2 | 27 | Sigma-Tau Research, Inc.INDUSTRY | 1 | Aug 28, 2012 | clinicaltrials |
| NCT00499681 | PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE | terminated | Phase 2 | 6 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT00611715 | Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer. | terminated | Phase 2 | 48 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT01597921 | A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer | terminated | — | 50 | Water-JelINDUSTRY | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00899288 | Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98 | terminated | Phase 3 | 60 | ETOP IBCSG Partners FoundationNETWORK | 0 | Jul 27, 2012 | clinicaltrials |
| NCT00006121 | Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | terminated | Phase 2 | 18 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 24, 2012 | clinicaltrials |
| NCT00516542 | Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 | 6 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 24, 2012 | clinicaltrials |
| NCT00010153 | ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer | terminated | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00028704 | Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy | terminated | Phase 3 | 26 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 18, 2012 | clinicaltrials |
| NCT00049660 | Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer | terminated | Phase 2 / Phase 3 | 47 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 18, 2012 | clinicaltrials |
| NCT00131924 | High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy | terminated | Phase 2 | 1 | Northwestern UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00276822 | Improving Communication With Patients With Breast Cancer | terminated | N/A | 30 | Northwestern UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00005608 | Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer | terminated | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00479856 | Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer | terminated | Phase 2 | 9 | GlaxoSmithKlineINDUSTRY | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00473005 | Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast | terminated | Phase 1 | 18 | Stanford UniversityOTHER | 1 | May 28, 2012 | clinicaltrials |
| NCT01362712 | Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects | terminated | Phase 1 | 7 | Siemens Molecular ImagingINDUSTRY | 1 | May 21, 2012 | clinicaltrials |
| NCT00607438 | A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 16 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00343512 | Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer | terminated | Phase 2 | 34 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 27, 2012 | clinicaltrials |
| NCT00241046 | Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment | terminated | Phase 4 | 13 | Novartis PharmaceuticalsINDUSTRY | 0 | Apr 19, 2012 | clinicaltrials |
| NCT01305239 | A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients(ETAPE) | terminated | — | 398 | PfizerINDUSTRY | 0 | Apr 10, 2012 | clinicaltrials |
| NCT01075607 | Lymph Fluid and Blood Collection for Identification of Novel Biomarkers | terminated | — | 50 | Indiana UniversityOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT00657137 | APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)(APRiCOT-B) | terminated | Phase 2 | 12 | Tragara Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00739063 | Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast Cancer | terminated | Phase 2 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00453635 | Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients | terminated | Phase 2 | 88 | Hellenic Oncology Research GroupOTHER | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00804544 | 99mTc-MIBI SPECT/CT in Breast Malignancy | terminated | N/A | 4 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Mar 5, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Feb 5, 2013source: clinicaltrials